20 Design and development of a novel digital shared decision making aid for glioblastoma patients

Clicks: 12
ID: 326671
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #278 of 287 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 287 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Introduction Facilitating shared decision-making (SDM) and incorporating patient decision aids are recommended by the National Institute for Health and Care Excellence (NICE). However, there is a lack of SDM aids for the specific treatment of high-grade glioma patients. The objective of this study was to describe the design and development process of a digital SDM aid for glioblastoma patients. Methods Following the International Patient Decision Aid Standards (IPDAS), the aid was developed through an iterative process with multi-disciplinary researchers, patient advocates, and a private tech company. The content of the SDM aid was developed by incorporating a prior study’s results, which highlighted several important health outcomes from brain tumor patients’ perspectives. Results The following components were considered when creating the SDM aid: patient feedback on important health outcomes (such as quality of life, maintaining cognitive function, survival rates, and post-operative care), delivery of information on glioblastoma and different treatment options, user engagement, accessibility, and inclusive communication. Conclusion A digital SDM aid was developed to support an SDM intervention for patients with glioblastoma. In a future study, we will test the effectiveness and determine the impact of the developed aid on facilitating the SDM process and health outcomes for patients with glioblastoma.
Reference Key
openalex_W7204439172 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag172.069
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.